Suchen
Oculis Holding AG
OCSZur Watchlist hinzufügen
14.120USD
+0.590+4.36%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
876.03MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Oculis Holding AG Unternehmen
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Oculis Holding AG Informationen
BörsenkürzelOCS
Name des UnternehmensOculis Holding AG
IPO-datumMar 03, 2023
CEOSherif (Riad)
Anzahl der mitarbeiter49
WertpapierartOrdinary Share
GeschäftsjahresendeMar 03
AddresseBahnhofstrasse 20
StadtZUG
BörseNASDAQ OMX - NASDAQ BASIC
LandSwitzerland
Postleitzahl6300
Telefon41417113960
Websitehttps://oculis.com/
BörsenkürzelOCS
IPO-datumMar 03, 2023
CEOSherif (Riad)
Führungskräfte von Oculis Holding AG
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
Dr. Riad Sherif, M.D.
Dr. Riad Sherif, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Anthony A. (Tony) Rosenberg
Mr. Anthony A. (Tony) Rosenberg
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Arshad M. Khanani, M.D.
Mr. Arshad M. Khanani, M.D.
Independent Director
Independent Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Oculis Holding AG?
Die fünf größten Anteilseigner von Oculis Holding AG sind: Mr. Martijn Kleijwegt
Wie viele Institutionen halten Anteile an Oculis Holding AG (OCS)?
Mit Stand vom 2026Q1 halten 72 Institutionen Anteile an Oculis Holding AG, mit einem Gesamtmarktwert von etwa 27.88M, was 54.68% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 2538023.00 gestiegen.